The president entered office seeking to overturn the Affordable Care Act, revamp Medicaid and drive down prescription drug prices, among other things. He’s hit some stone walls.
The announcement clears the way for Florida and other states to implement a program bringing medications across the border to save money. The effort is strongly opposed by drugmakers and the Canadian government.
Few places loom as large in the race for the White House as here in Pinellas County, the largest swing county in the ultimate swing state. And polls show that many people will have the pandemic and its public health and economic consequences on their minds when they cast their votes.
The Trump administration is primed to approve a plan designed to help lower costs of some prescription drugs by allowing states to import them from Canada. The announcement could come before Election Day, and Florida appears to be in line to go first.
Once there were 23 of these nonprofit plans across 26 states; in January there will be only three, serving Maine, Wisconsin, Montana, Idaho and Wyoming.
Although it is still early, available numbers provide backup.
Pennsylvania and New Jersey are leaving the federal marketplace this fall to save money and will start their own insurance exchanges. Kentucky, New Mexico, Virginia and Maine are looking to join them in 2021 or beyond.
People have flooded U.S. testing sites with requests to participate in the pivotal, late-stage clinical trials of the first two COVID-19 vaccine candidates.
For the first time since 2017, Medicaid enrollment has begun increasing again, but not by as much as many analysts expected.
With COVID-19 tests bogged down in backlogs, some states that relied on private laboratories, such as Quest Diagnostics, are trying to adapt as caseloads rise.